CN Patent

CN102459596B — 通过针对脂质转运和代谢基因的天然反义转录物的抑制治疗脂质转运和代谢基因相关疾病

Assigned to Opko Curna LLC · Expires 2016-09-07 · 10y expired

What this patent protects

本发明涉及反义寡核苷酸，其调节脂质转运和代谢基因的表达和/或功能，尤其是通过靶向脂质转运和代谢基因的天然反义多核苷酸。本发明也涉及这些反义寡核苷酸的鉴定及其在治疗与脂质转运和代谢基因表达有关的疾病和病症中的应用。

USPTO Abstract

本发明涉及反义寡核苷酸，其调节脂质转运和代谢基因的表达和/或功能，尤其是通过靶向脂质转运和代谢基因的天然反义多核苷酸。本发明也涉及这些反义寡核苷酸的鉴定及其在治疗与脂质转运和代谢基因表达有关的疾病和病症中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102459596B
Jurisdiction
CN
Classification
—
Expires
2016-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Opko Curna LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.